IMPACT-HTN Study of Patients With Hypertension

Starting soon

Conditions studied: Hypertension (HTN), Hypertension, Blood Pressure, High

In brief

An estimated 120 million people have high blood pressure (hypertension) in the US, of which approximately 10% have resistant hypertension. This study aims to enroll patients who continue to have hypertension while being treated with at least two medications. The study will follow patients for approximately 3 months and collect real-world information on changes in their health to identify an ideal patient profile that would benefit from 4th-line antihypertensive therapies, including, but not limited to, FDA-approved aprocitentan, renal denervation, mineralocorticoid receptor antagonists, etc.

Key facts

Study ID
NCT07579260
Run by
Vivek Bhalla
People needed
100
Starts
2026-07-01
Expected to finish
2027-04-01
Last updated by the study team
2026-06-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.